Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis

Zuzhen Ou, Chao Chen,Aijun Chen,Yao Yang,Weikang Zhou

International Immunopharmacology（2018）

引用 120|浏览3

暂无评分

摘要

•Dupilumab moderately reduced the risk of skin infection and the exacerbation of AD.•Dupilumab slightly increased the risk of headache.•Dupilumab moderately increased the risk of injection-site reaction and conjunctivitis.•Dupilumab had little effect on upper respiration infection.

查看译文

关键词

Dupilumab,Atopic dermatitis,Adverse events,Meta-analysis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要